Get the Stockscreener App
225.00
3.62%
-8.46
After Hours:
225.00
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $225.00, with a volume of 1.42M.
It is down -3.62% in the last 24 hours and down -12.39% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$233.46
Open:
$231.5
24h Volume:
1.42M
Relative Volume:
2.36
Market Cap:
$18.83B
Revenue:
$12.71B
Net Income/Loss:
$435.50M
P/E Ratio:
43.69
EPS:
5.15
Net Cash Flow:
$843.20M
1W Performance:
-2.18%
1M Performance:
-12.39%
6M Performance:
+4.17%
1Y Performance:
+6.53%
1-Day Range:
$222.28
$233.74
1-Week Range:
$222.28
$238.39
52-Week Range:
$191.97
$258.59
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
225.00 | 18.83B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
437.91 | 165.21B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
181.77 | 130.05B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
393.73 | 31.91B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
103.00 | 29.38B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
154.73 | 27.28B | 15.41B | 1.37B | 2.11B | 7.50 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Here's Why Labcorp (LH) is a Strong Growth Stock - Yahoo Finance
Assessing Labcorp Hldgs: Insights From 8 Financial Analysts - Benzinga
Labcorp Launches New Blood Test to Diagnose Alzheimer's Disease - MarketScreener
LH Stock to Gain From Launch of HPV and STI Self-Collection Options - TradingView
Game-Changing Alzheimer's Blood Test Achieves 95% Accuracy, Revolutionizing Diagnosis - Stock Titan
Redburn Atlantic Initiates Labcorp Holdings at Buy With $276 Price Target - MarketScreener
Esoteric Testing Market Deep Research 2025-2032 | LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings - openPR.com
Labcorp Launches First-Of-Its-Kind Immunoassay To Accelerate Path To Diagnosis Of Alzheimer's Disease - MarketScreener
Labcorp Holdings (NYSE:LH) Introduces FDA-Approved Self-Collection Tests For HPV And STIs - simplywall.st
Labcorp to Announce First Quarter Financial Results on April 29, 2025 - Eastern Progress
Labcorp to offer HPV and STI self-collection solutions - TipRanks
Game-Changing HPV Testing: Labcorp Rolls Out Private Self-Collection Options Nationwide - Stock Titan
Labcorp Holdings to Announce Q1 2025 Financial Results - TipRanks
Labcorp Earnings Preview: Q1 2025 Results Coming April 29Key Updates Expected - Stock Titan
Labcorp holdings EVP Amy Summy sells $175,605 in stock By Investing.com - Investing.com Canada
Labcorp holdings EVP Amy Summy sells $175,605 in stock - Investing.com
LabCorp EVP Mark Schroeder sells $610,450 in stock - Investing.com
LabCorp EVP Mark Schroeder sells $610,450 in stock By Investing.com - Investing.com UK
Baird Adjusts Labcorp Holdings Price Target to $292 From $293, Maintains Outperform Rating - MarketScreener
Labcorp 401(k) Plan Fee Class Action Gets Green Light for Trial - news.bloombergtax.com
Labcorp Denied Early Win In 401(k) Fee Suit - Law360
Is Labcorp Holdings Stock Outperforming the Nasdaq? - MSN
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack - Yahoo Finance
Labcorp to close Los Angeles site, lay off 73 people - Yahoo Finance
Why Labcorp (LH) is a Top Growth Stock for the Long-Term - Yahoo Finance
Labcorp Holdings Inc. (NYSE:LH) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed? - simplywall.st
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Labcorp Holdings (LH) and Arcutis Biotherapeutics (ARQT) - The Globe and Mail
Labcorp is Set to Acquire Select Assets of BioReference Health of OPK - Yahoo Finance
Labcorp Warns Fed. Circ. Of 'Balkanization' In Prenatal IP Row - Law360
Labcorp’s SWOT analysis: clinical testing giant’s stock faces growth opportunities - Investing.com
Labcorp to acquire certain assets of Opko Health’s BioReference Health - Yahoo Finance
Truist remains bullish on Labcorp after ‘another nice strategic acquisition’ - Yahoo Finance
Labcorp to buy Opko unit’s cancer test assets for up to $225M - Yahoo Finance
Labcorp to acquire BioReference Health assets for up to $225M By Investing.com - Investing.com Canada
Truist maintains Buy on LabCorp stock, keeps $285 target By Investing.com - Investing.com Canada
Opko Health Sells BioReference Assets to Labcorp - TipRanks
Labcorp Announces Acquisition Of Select Assets Of Bioreference Health's Innovative Oncology And Related Clinical Testing Services Businesses - Marketscreener.com
Labcorp to buy certain assets of OPKO unit BioReference Health - MSN
Labcorp stock gains on deal to buy OPKO assets (LH:NYSE) - Seeking Alpha
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million - MarketWatch
Labcorp To Buy Certain Assets Of BioReference Health For A Maximum $225 Mln - Nasdaq
Labcorp's $225M Oncology Testing Expansion: Strategic BioReference Assets Acquisition Promises Market Growth - StockTitan
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Labcorp Holdings' (NYSE:LH) Strong Earnings Are Of Good Quality - Yahoo Finance
Labcorp director Anderson sells shares for $127,817 By Investing.com - Investing.com Australia
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN
Labcorp director Anderson sells shares for $127,817 - Investing.com
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):